Healthcare Sales & Marketing Network News: FIBRILLEX

Searching News Database: FIBRILLEX

HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Feb 2007
Neurochem receives second recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Feb 2007
Neurochem announcement regarding the completion of its North American phase III clinical trial for tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Nov 2006
Tramiprosate (ALZHEMED(TM)) Phase II Clinical Results Published in Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Biopharmaceuticals

Return to NewsFeed

Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 22 additional stories matching:
FIBRILLEX
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.